McKesson (MCK)
(Real Time Quote from BATS)
$550.90 USD
+3.43 (0.63%)
Updated Aug 27, 2024 02:44 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
McKesson (MCK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$635.29 | $671.00 | $570.00 | 16.04% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for McKesson comes to $635.29. The forecasts range from a low of $570.00 to a high of $671.00. The average price target represents an increase of 16.04% from the last closing price of $547.47.
Analyst Price Targets (14)
Broker Rating
McKesson currently has an average brokerage recommendation (ABR) of 1.41 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 1.41 a month ago based on 16 recommendations.
Of the 16 recommendations deriving the current ABR, 12 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 75% and 6.25% of all recommendations. A month ago, Strong Buy made up 75%, while Buy represented 6.25%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MCK.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 12 | 12 | 12 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.41 | 1.41 | 1.41 | 1.41 | 1.41 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/8/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
8/8/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/22/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
7/9/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
7/8/2024 | SVB Securities | Michael Cherny | Strong Buy | Strong Buy |
5/9/2024 | Wells Fargo Securities | Stephen Baxter | Hold | Hold |
5/7/2024 | Not Identified | Not Identified | Hold | Hold |
4/30/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/10/2024 | Argus Research Corp. | David A Toung | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.41 |
ABR (Last week) | 1.41 |
# of Recs in ABR | 16 |
Average Target Price | $635.29 |
LT Growth Rate | 13.60% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 170 of 253 |
Current Quarter EPS Est: | 7.47 |